Boehringer FY oper profit up 20 pct on Pradaxa pill
Posted on April 24, 2012 at 04:30 AM EDT
FRANKFURT, April 24 (Reuters) - Boehringer Ingelheim, the world's largest unlisted drugmaker, said 2011 operating profit jumped 20 percent, boosted by sales of its anti-blood-clotting drug Pradaxa.